CNS can tailor treatment for post-COVID-19 patients who experience neurological complications as a result of the virus. These can include stroke, encephalitis and respiratory distress. Comorbidities related to severe COVID-19 can also be addressed in tandem with neurorehabilitation offered at CNS. Cognitive impairment, memory loss and attention deficits can be associated with infection and are core components of care at all facilities.
COVID-19 Neurological Diagnosis
Stroke
Critical illness myopathy or neuropathy
Anoxic brain injury secondary to cardiac arrest or respiratory distress
Encephalitis
Guillain-Barre syndrome
Severe COVID-19 Prolonged Illness Comorbidities
Post ICU Syndrome
Hospital Delirium
Motor Weakness
Attention Deficit or Impulsivity
Cognitive Impairment
Memory Loss
Sundowners Syndrome
Depression or Anxiety
PTSD or Agoraphobia
Insomnia or Fatigue
Confusion or Disorientation
Loss of Smell or Taste
BIAA Guidance on COVID Vaccines for Persons with Brain Injury
The medical leadership of the Brain Injury Association of America (BIAA) wrote an open letter encouraging all individuals with brain injury to get vaccinated to avoid additional neuroinflammatory issues and keep themselves, their families, and their communities safe.
CNS Monthly Newsletter
The latest CNS updates, including events, company information, and patient care developments
The Inside View
Quarterly magazine focused on brain injury research, rehabilitation, and advancements shaping the field
Sign-up for one or both to stay connected with brain injury news and recovery
